Skip to main content
Caplight Logo









Nobio

Nobio

Private
IsraelHealthcare & Life Scienceshttps://nobio.com

Last Round

Grant

Apr 9, 2020

Total Funding Raised

$6.55M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nobio operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in April 2020.

Nobio is a biotechnology company that develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nobio Comparables

Compare Nobio with similar companies based on industry and business-model similarity.

Nobio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulpdent Corporation
79%
FiteBac Dental
79%
Mesosil
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nobio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 9, 2020
GrantMay 1, 2019
SeedJul 30, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Natan Zaltsman

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Nobio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 71% MoM, reaching 3K.

  • Jul 26, 2026

    Monthly visitors grew 35% MoM, reaching 1.8K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nobio Filings

Explore SEC and related filing metadata, where available.

Nobio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nobio's valuation, stock price, and market status.

Is Nobio a public or private company?

Nobio is a private company.

What is the current stock price of Nobio?

Nobio is a private company, so its shares have no public market price. Caplight tracks Nobio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nobio worth (valuation)?

Valuation information for Nobio is not publicly available.

Can I buy Nobio stock?

Nobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nobio's last funding round?

Nobio's most recent funding round was Grant on April 9, 2020.

Who are the main investors in Nobio?

Key investors in Nobio include aMoon.

Will Nobio IPO soon?

No public IPO plans have been announced for Nobio.

How can I track Nobio secondary market activity?

Caplight tracks bids, offers, and trades in Nobio's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range14
Year Founded2015
Last FundingApr 9, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?